文献速递认知障碍与痴呆

AV-1451 tau与β-淀粉样蛋白PET在路易体痴呆中的成像

AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
PubMed 文献 · Ann Neurol · 2016-12-19

本研究比较了临床很可能路易体痴呆(DLB)患者与阿尔茨海默病(AD)痴呆患者及正常对照的AV-1451 tau PET摄取模式及其与PiB β-淀粉样蛋白沉积的关系。结果显示AD痴呆组AV-1451摄取显著高于DLB组,且内侧颞叶摄取可完全区分两者;DLB组在后颞顶叶和枕叶皮质摄取高于正常对照,并与全局皮质PiB摄取相关。

要点

  • 内侧颞叶AV-1451摄取可区分AD痴呆与很可能DLB。
  • 很可能DLB在后颞顶叶和枕叶皮质AV-1451摄取高于正常对照。
  • 很可能DLB中这些区域摄取与全局皮质PiB摄取相关。

核心结论

  • 内侧颞叶AV-1451摄取可区分AD痴呆与很可能DLB,有助于鉴别诊断。
  • 很可能DLB在后颞顶叶和枕叶AV-1451摄取升高并与全局皮质PiB摄取相关,提示非典型tau沉积模式。

研究设计与样本

  • 连续纳入Mayo Clinic阿尔茨海默病研究中心临床很可能DLB患者19例,进行MRI、AV-1451和PiB PET检查。
  • 年龄性别匹配的AD痴呆患者19例和临床正常对照95例作为比较组。
  • 采用基于图谱和体素的分析方法。

主要发现

  • AD痴呆组AV-1451摄取显著高于很可能DLB组,内侧颞叶摄取完全区分AD痴呆与很可能DLB。
  • 很可能DLB组后颞顶叶和枕叶皮质AV-1451摄取高于临床正常对照。
  • 很可能DLB组这些区域AV-1451摄取与全局皮质PiB摄取相关(Spearman rho=0.63;p=0.006)。

临床怎么用

  • 内侧颞叶AV-1451摄取可用于AD痴呆与很可能DLB的鉴别诊断。
  • 很可能DLB患者出现后颞顶叶和枕叶AV-1451摄取升高时,需考虑非典型tau沉积模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with probable dementia with Lewy bodies (DLB) often have Alzheimer's disease (AD)-related pathology. Our objective was to determine the pattern of positron emission tomography (PET) tau tracer AV-1451 uptake in patients with probable DLB, compared to AD, and its relationship to β-amyloid deposition on PET. METHODS: Consecutive patients with clinically probable DLB (n = 19) from the Mayo Clinic Alzheimer's Disease Research Center underwent magnetic resonance imaging, AV-1451, and Pittsburgh compound-B (PiB) PET examinations. Age- and sex-matched groups of AD dementia (n = 19) patients and clinically normal controls (n = 95) from an epidemiological cohort served as a comparison groups. Atlas- and voxel-based analyses were performed. RESULTS: The AD dementia group had significantly higher AV-1451 uptake than the probable DLB group, and medial temporal uptake completely distinguished AD dementia from probable DLB. Patients with probable DLB had greater AV-1451 uptake in the posterior temporoparietal and occipital cortex compared to clinically normal controls, and in probable DLB, the uptake in these regions correlated with global cortical PiB uptake (Spearman rho = 0.63; p = 0.006). INTERPRETATION: Medial temporal lobe AV-1451 uptake distinguishes AD dementia from probable DLB, which may be useful for differential diagnosis. Elevated posterior temporoparietal and occipital AV-1451 uptake in probable DLB and its association with global cortical PiB uptake suggest an atypical pattern of tau deposition in DLB. ANN NEUROL 2017;81:58-67.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Kantarci K, Lowe VJ, Boeve BF, et al. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies. Ann Neurol. 2016. PMID: 27863444. doi:10.1002/ana.24825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。